Longitudinal BCVA Analysis of Low- or High -Dose MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmentosa: 12-Month Results from a Phase 2b/3 Randomized, Sham Controlled, Patient- and Assessor Masked Clinical Trial (RESTORE)
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined